Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Promotion of B Cell Immune Responses via an Alum-Induced Myeloid Cell Population
Michael B. Jordan,1,2*
David M. Mills,1*
John Kappler,1,3
Philippa Marrack,1,3
John C. Cambier1
Abstract:
Exposure of naïve B cells to the cytokine interleukin-4(IL-4) and/or antigen leads to a state of "priming," in whichsubsequent aggregation of major histocompatibility complex classII molecules induces the mobilization of calcium ions and cellproliferation. However, it is not clear how critical this primingis for immune responses or how it is normally induced in vivo.Injection of mice with the commonly used adjuvant alum led topriming of splenic B cells and to the accumulation in the spleenof a previously unknown population of IL-4producing,Gr1+ cells. These cells and IL-4 were both required for in vivopriming and expansion of antigen-specific B cells, as well asfor optimal production of antibody. These studies reveal a keyrole for a previously unknown accessory myeloid cell populationin the generation of humoral immune responses.
1 Integrated Department of Immunology, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, 1400 Jackson Street, Denver, CO 80206, USA. 2 Department of Pediatrics, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, 1400 Jackson Street, Denver, CO 80206, USA. 3 Howard Hughes Medical Institute, Denver, CO 80206, USA.
Type II NKT cells facilitate Alum-sensing and humoral immunity.
H. B. Shah, T. S. Devera, P. Rampuria, G. A. Lang, and M. L. Lang (2012)
J. Leukoc. Biol.
92, 883-893
|Abstract »|Full Text »|PDF »
Intranasal Immunization with a Formalin-Inactivated Human Influenza A Virus Whole-Virion Vaccine Alone and Intranasal Immunization with a Split-Virion Vaccine with Mucosal Adjuvants Show Similar Levels of Cross-Protection.
S. Okamoto, S. Matsuoka, N. Takenaka, A. M. Haredy, T. Tanimoto, Y. Gomi, T. Ishikawa, T. Akagi, M. Akashi, Y. Okuno, et al. (2012)
Clin. Vaccine Immunol.
19, 979-990
|Abstract »|Full Text »|PDF »
Phenotypic, Morphological, and Functional Heterogeneity of Splenic Immature Myeloid Cells in the Host Response to Tularemia.
J. W. Rasmussen, J. W. Tam, N. A. Okan, P. Mena, M. B. Furie, D. G. Thanassi, J. L. Benach, and A. W. M. van der Velden (2012)
Infect. Immun.
80, 2371-2381
|Abstract »|Full Text »|PDF »
Comparative Evaluation of Two Hemagglutinating Encephalomyelitis Coronavirus Vaccine Candidates in Mice.
K. Chen, K. Zhao, W. He, W. Gao, C. Zhao, L. Wang, W. Pan, D. Song, C. Wang, and F. Gao (2012)
Clin. Vaccine Immunol.
19, 1102-1109
|Abstract »|Full Text »|PDF »
Antigen depot is not required for alum adjuvanticity.
S. Hutchison, R. A. Benson, V. B. Gibson, A. H. Pollock, P. Garside, and J. M. Brewer (2012)
FASEB J
26, 1272-1279
|Abstract »|Full Text »|PDF »
Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).
Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo.
M. W. Munks, A. S. McKee, M. K. MacLeod, R. L. Powell, J. L. Degen, N. A. Reisdorph, J. W. Kappler, and P. Marrack (2010)
Blood
116, 5191-5199
|Abstract »|Full Text »|PDF »
Vaccine-Induced Antibody Isotypes Are Skewed by Impaired CD4 T Cell and Invariant NKT Cell Effector Responses in MyD88-Deficient Mice.
O. I. Iweala, D. W. Smith, K. S. Matharu, I. Sada-Ovalle, D. D. Nguyen, R. H. DeKruyff, D. T. Umetsu, S. M. Behar, and C. R. Nagler (2009)
J. Immunol.
183, 2252-2260
|Abstract »|Full Text »|PDF »
STIM1-Independent T Cell Development and Effector Function In Vivo.
N. Beyersdorf, A. Braun, T. Vogtle, D. Varga-Szabo, R. R. Galdos, S. Kissler, T. Kerkau, and B. Nieswandt (2009)
J. Immunol.
182, 3390-3397
|Abstract »|Full Text »|PDF »
HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection.
E. Fanales-Belasio, S. Moretti, V. Fiorelli, A. Tripiciano, M. R. Pavone Cossut, A. Scoglio, B. Collacchi, F. Nappi, I. Macchia, S. Bellino, et al. (2009)
J. Immunol.
182, 2888-2897
|Abstract »|Full Text »|PDF »
Allergic Airway Hyperresponsiveness-Enhancing {gamma}{delta} T Cells Develop in Normal Untreated Mice and Fail to Produce IL-4/13, Unlike Th2 and NKT Cells.
N. Jin, C. L. Roark, N. Miyahara, C. Taube, M. K. Aydintug, J. M. Wands, Y. Huang, Y.-S. Hahn, E. W. Gelfand, R. L. O'Brien, et al. (2009)
J. Immunol.
182, 2002-2010
|Abstract »|Full Text »|PDF »
Dendritic Cells and Monocyte/Macrophages That Create the IL-6/APRIL-Rich Lymph Node Microenvironments Where Plasmablasts Mature.
E. Mohr, K. Serre, R. A. Manz, A. F. Cunningham, M. Khan, D. L. Hardie, R. Bird, and I. C. M. MacLennan (2009)
J. Immunol.
182, 2113-2123
|Abstract »|Full Text »|PDF »
Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3.
H. Li, S. B. Willingham, J. P.-Y. Ting, and F. Re (2008)
J. Immunol.
181, 17-21
|Abstract »|Full Text »|PDF »
Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses.
A. S. McKee, M. MacLeod, J. White, F. Crawford, J. W. Kappler, and P. Marrack (2008)
Int. Immunol.
20, 659-669
|Abstract »|Full Text »|PDF »
The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells.
A. Seubert, E. Monaci, M. Pizza, D. T. O'Hagan, and A. Wack (2008)
J. Immunol.
180, 5402-5412
|Abstract »|Full Text »|PDF »
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells.
M. Kool, T. Soullie, M. van Nimwegen, M. A.M. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht (2008)
J. Exp. Med.
205, 869-882
|Abstract »|Full Text »|PDF »
Pivotal Advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production.
T. Doi, K. Obayashi, T. Kadowaki, H. Fujii, and S. Koyasu (2008)
Int. Immunol.
20, 499-508
|Abstract »|Full Text »|PDF »
Complement Receptors 1 and 2 Influence the Immune Environment in a B Cell Receptor-Independent Manner.
A. C. Jacobson, J. J. Weis, and J. H. Weis (2008)
J. Immunol.
180, 5057-5066
|Abstract »|Full Text »|PDF »
MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis.
M. J. Delano, P. O. Scumpia, J. S. Weinstein, D. Coco, S. Nagaraj, K. M. Kelly-Scumpia, K. A. O'Malley, J. L. Wynn, S. Antonenko, S. Z. Al-Quran, et al. (2007)
J. Exp. Med.
204, 1463-1474
|Abstract »|Full Text »|PDF »
Neonatal human autologous dendritic cells pulsed with recombinant protein antigen prime the generation of non-polarized CD4 T-cell effectors.
N. C. Matthews, U. F. Power, and D. J. Reen (2007)
Int. Immunol.
19, 703-712
|Abstract »|Full Text »|PDF »
Critical Role of the Fc Receptor {gamma}-Chain on APCs in the Development of Allergen-Induced Airway Hyperresponsiveness and Inflammation.
K. Kitamura, K. Takeda, T. Koya, N. Miyahara, T. Kodama, A. Dakhama, T. Takai, A. Hirano, M. Tanimoto, M. Harada, et al. (2007)
J. Immunol.
178, 480-488
|Abstract »|Full Text »|PDF »
Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes..
K. Zaks, M. Jordan, A. Guth, K. Sellins, R. Kedl, A. Izzo, C. Bosio, and S. Dow (2006)
J. Immunol.
176, 7335-7345
|Abstract »|Full Text »|PDF »
CD1d-Independent Developmental Acquisition of Prompt IL-4 Gene Inducibility in Thymus CD161(NK1)-CD44lowCD4+CD8- T Cells Is Associated with Complementarity Determining Region 3-Diverse and Biased V{beta}2/V{beta}7/V{beta}8/V{alpha}3.2 T Cell Receptor Usage.
V{alpha}14 NK T cell-triggered IFN-{gamma} production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets.
Y. Yasunami, S. Kojo, H. Kitamura, A. Toyofuku, M. Satoh, M. Nakano, K. Nabeyama, Y. Nakamura, N. Matsuoka, S. Ikeda, et al. (2005)
J. Exp. Med.
202, 913-918
|Abstract »|Full Text »|PDF »
Antinuclear Antigen B Cells That Down-Regulate Surface B Cell Receptor during Development to Mature, Follicular Phenotype Do Not Display Features of Anergy In Vitro.
Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection.
T. Ichinohe, I. Watanabe, S. Ito, H. Fujii, M. Moriyama, S.-i. Tamura, H. Takahashi, H. Sawa, J. Chiba, T. Kurata, et al. (2005)
J. Virol.
79, 2910-2919
|Abstract »|Full Text »|PDF »
Mismatched Antigen Prepares {gamma}{delta} T Cells for Suppression of Airway Hyperresponsiveness.
N. Jin, C. Taube, L. Sharp, Y.-S. Hahn, X. Yin, J. M. Wands, C. L. Roark, R. L. O'Brien, E. W. Gelfand, and W. K. Born (2005)
J. Immunol.
174, 2671-2679
|Abstract »|Full Text »|PDF »
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.
N. Takasuka, H. Fujii, Y. Takahashi, M. Kasai, S. Morikawa, S. Itamura, K. Ishii, M. Sakaguchi, K. Ohnishi, M. Ohshima, et al. (2004)
Int. Immunol.
16, 1423-1430
|Abstract »|Full Text »|PDF »